These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9058587)
1. The Supreme Court rules on medical device liability--or does it? Richards EP IEEE Eng Med Biol Mag; 1997; 16(1):87-8, 90. PubMed ID: 9058587 [No Abstract] [Full Text] [Related]
2. The deregulatory effects of preempting tort litigation: FDA regulation of medical devices. Gostin LO JAMA; 2008 May; 299(19):2313-6. PubMed ID: 18492972 [No Abstract] [Full Text] [Related]
3. Section 8(c) of the proposed Restatement (Third) of Torts: is it really what the doctor ordered? Winchester JD Cornell Law Rev; 1997 Mar; 82(3):644-93. PubMed ID: 10343053 [No Abstract] [Full Text] [Related]
4. Tort litigation and federal regulation of medical devices. Piwinski S; Fitzpatrick S JAMA; 2008 Oct; 300(16):1881-2; author reply 1882. PubMed ID: 18940973 [No Abstract] [Full Text] [Related]
5. The forces that threaten the U.S. medical device industry. Benson JS ASAIO J; 1995; 41(3):M238-41. PubMed ID: 8573796 [No Abstract] [Full Text] [Related]
6. Patent issue: supplier liability in medical implants and devices: the "Biomaterials Access Assurance Act". Pabst PL; Mills KV Tissue Eng; 2000 Apr; 6(2):189-90. PubMed ID: 10941213 [No Abstract] [Full Text] [Related]
7. The preemptive scope of the Medical Device Amendments of 1976. Sunshine PH Food Drug Law J; 1995; 50(1):191-212. PubMed ID: 10342991 [No Abstract] [Full Text] [Related]
8. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine. Murdey J Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848 [TBL] [Abstract][Full Text] [Related]
10. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety. Kesselheim AS Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322 [TBL] [Abstract][Full Text] [Related]
11. The medical device industry. Szycher M J Biomater Appl; 1996 Jul; 11(1):76-118. PubMed ID: 8872601 [No Abstract] [Full Text] [Related]
12. U.S. FDA rules for device investigations. Munzner R IEEE Eng Med Biol Mag; 2003; 22(1):95-6. PubMed ID: 12683070 [No Abstract] [Full Text] [Related]
13. The FDA, preemption, and the Supreme Court. Glantz LH; Annas GJ N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601 [No Abstract] [Full Text] [Related]
14. The Federal Food and Drug Administration. Cooney WP J Am Acad Orthop Surg; 2008 May; 16(5):241-2. PubMed ID: 18460683 [No Abstract] [Full Text] [Related]
15. Court rules generic drug companies not responsible for adverse outcomes. Kouros N Monash Bioeth Rev; 2013 Sep; 31(2):23-4. PubMed ID: 24844072 [No Abstract] [Full Text] [Related]
17. A pivotal medical-device case. Greenspan H N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514 [No Abstract] [Full Text] [Related]
18. Forces reshaping the performance and contribution of the U.S. medical device industry. Benson JS Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326 [No Abstract] [Full Text] [Related]
19. Ejecting the FDA from the courtroom. Lancet; 2004 Aug 21-27; 364(9435):638. PubMed ID: 15325808 [No Abstract] [Full Text] [Related]
20. Medical devices legislation--for tomorrow's patients, as well as today's. Kimbell JT J Assoc Adv Med Instrum; 1971; 5(5):306-9. PubMed ID: 5118232 [No Abstract] [Full Text] [Related] [Next] [New Search]